Eledon Pharmaceuticals In... (ELDN)
Eledon Pharmaceuticals Statistics
Share Statistics
Eledon Pharmaceuticals has 59.88M shares outstanding. The number of shares has increased by 55.51% in one year.
| 59.88M |
| 55.51% |
| 0.24% |
| 74.08% |
| n/a |
| 6,695 |
| 3.02% |
Short Selling Information
The latest short interest is 1.57M, so 2.62% of the outstanding shares have been sold short.
| 1.57M |
| 2.62% |
| 2.92% |
| 7.92 |
Valuation Ratios
The PE ratio is -5.66 and the forward PE ratio is -3.49. Eledon Pharmaceuticals's PEG ratio is 0.
| -5.66 |
| -3.49 |
| 0 |
| 3.3 |
| 1.69 |
| -4.23 |
| 0 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Eledon Pharmaceuticals.
| n/a |
| n/a |
| n/a |
| n/a |
Financial Position
The company has a current ratio of 12.42, with a Debt / Equity ratio of 0.01.
| 12.42 |
| 12.42 |
| 0.01 |
| -0.03 |
| -0.02 |
| 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| n/a |
| n/a |
| n/a |
| n/a |
| $-1,139,419.35 |
| 31 |
| 0 |
| n/a |
Taxes
| 431K |
| -1.21% |
Stock Price Statistics
The stock price has increased by 6.69% in the last 52 weeks. The beta is -0.16, so Eledon Pharmaceuticals's price volatility has been lower than the market average.
| -0.16 |
| 6.69% |
| 3.1 |
| 3.6 |
| 47.73 |
| 221,396 |
Balance Sheet
The company has 20.55M in cash and 954K in debt, giving a net cash position of 19.59M.
| 20.55M |
| 954K |
| 19.59M |
| -355.59M |
| 161.31M |
| 118.53M |
Cash Flow
In the last 12 months, operating cash flow was -47.27M and capital expenditures 0, giving a free cash flow of -47.27M.
| -47.27M |
| n/a |
| -47.27M |
| -0.97 |
Margins
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Dividends & Yields
ELDN does not appear to pay any dividends at this time.
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Analyst Forecast
The average price target for ELDN is $16, which is 428.1% higher than the current price. The consensus rating is "Buy".
| $16 |
| 428.1% |
| Buy |
| 1 |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| n/a |
| n/a |
| n/a |
| n/a |
Stock Splits
The last stock split was on Oct 5, 2020. It was a backward split with a ratio of 1:18.
| Oct 5, 2020 |
| backward |
| 1:18 |
Scores
| -1.43 |
| 2 |